✦ LIBER ✦

Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer

✍ Scribed by Sonnenblick, Amir; Uziely, Beatrice; Nechushtan, Hovav; Kadouri, Luna; Galun, Eithan; Axelrod, Jonathan H.; Katz, Daniela; Daum, Hagit; Hamburger, Tamar; Maly, Bela; Allweis, Tanir M.; Peretz, Tamar

Book ID: 120377611
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 218 KB
Volume: 138
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-013-2453-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor Microsatellite-Instability Status

Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer

✍ Ribic, Christine M.; Sargent, Daniel J.; Moore, Malcolm J.; Thibodeau, Stephen N 📂 Article 📅 2003 🏛 Massachusetts Medical Society 🌐 English ⚖ 134 KB

Primary Tumor Response to Induction Chem

Primary Tumor Response to Induction Chemotherapy as a Predictor of Histological Status of Axillary Nodes in Operable Breast Cancer Patients

✍ Jeffrey T. Lenert; Georges Vlastos; Nadem Q. Mirza; David J. Winchester; Susanne 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 50 KB

Is TIMP-1 immunoreactivity alone or in c

Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?

✍ Alison F Munro, Annette Bartels, Eva Balslev… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 417 KB

Cross-validation study of class III beta

Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials

✍ Reiman, T.; Lai, R.; Veillard, A. S.; Paris, E.; Soria, J. C.; Rosell, R.; Taron 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 191 KB

Decreased immunoreactivity for p27 prote

Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status : Results from International Breast Cancer Study Group Trial V

✍ Vito J. Spataro; Heather Litman; Giuseppe Viale; Fausto Maffini; Michele Masullo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to clarify the prognostic and predictive value of immunoreactivity for the cyclin‐dependent kinase inhibitor p27(Kip1) in patients with early‐stage breast carcinoma and to investigate its relation with clinicopathologic features and other m